Inogen Inc (NASDAQ:INGN) shares traded -0.19% lower at $10.64 on Wall Street last session.
INGN stock price is now 5.37% away from the 50-day moving average and 10.02% away from the 200-day moving average. The market capitalization of the company currently stands at $253.44M.
On August 08, 2023, JP Morgan Downgraded its previous ‘Overweight’ rating to ‘Neutral’ on the stock reducing its target price from $15 to quote $8, while ‘Needham’ rates the stock as ‘Hold’
In other news, JASON SOMER, Officer bought 4,690 shares of the company’s stock on Aug 09 ’24. The stock was bought for $56,423 at an average price of $12.03. An SEC document containing details of the transaction can be found on the SEC’s website. On May 10 ’24, EVP, Gen. Counsel & Secretary Somer Jason sold 10,000 shares of the business’s stock. A total of $85,600 was realized by selling the stock at an average price of $8.56. This leaves the insider owning 4,452 shares of the company worth $47369.28. A total of 1.71% of the company’s stock is owned by insiders.
During the past 12 months, Inogen Inc has had a low of $5.82 and a high of $13.33. As of last week, the company has a debt-to-equity ratio of 0.11, a current ratio of 2.66, and a quick ratio of 2.34. The fifty day moving average price for INGN is $10.0978 and a two-hundred day moving average price translates $9.6714 for the stock.
The latest earnings results from Inogen Inc (NASDAQ: INGN) was released for 2024-09-30. The net profit margin was -15.89% and return on equity was -25.33% for INGN. The company reported revenue of $88.83 million for the quarter, compared to $83.97 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.8 percent.
